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Abstract
Background: Bacterial penicillin-binding proteins (PBPs) can be visualized by their ability to bind radiolabeled or
fluorescent b-lactam derivatives both whole cells and membrane/cell enriched fractions. Analysis of the Listeria
monocytogenes genome sequence predicted ten genes coding for putative PBPs, but not all of their products have
been detected in studies using radiolabeled antibiotics, thus hindering their characterization. Here we report the
positive identification of the full set of L. monocytogenes PBPs and the characteristics of the hitherto undescribed
PBPD2 (Lmo2812).
Results: Eight L. monocytogenes PBPs were identified by the binding of fluorescent b-lactam antibiotic derivatives
Boc-FL, Boc-650 and Amp-Alexa430 to proteins in whole cells or membrane/cell wall extracts. The gene encoding a
ninth PBP (Lmo2812) was cloned and expressed in Escherichia coli as a His-tagged protein. The affinity purified
recombinant protein had DD-carboxypeptidase activity and preferentially degraded low-molecular-weight
substrates. L. monocytogenes mutants lacking the functional Lmo2812 enzyme were constructed and, compared to
the wild-type, the cells were longer and slightly curved with bent ends.
Protein Lmo1855, previously designated PBPD3, did not bind any of the antibiotic derivatives tested, similarly to
the homologous enterococcal protein VanY.
Conclusions: Nine out of the ten putative L. monocytogenes PBP genes were shown to encode proteins that bind
derivatives of b-lactam antibiotics, thus enabling their positive identification. PBPD2 (Lmo2812) was not visualized
in whole cell extracts, most probably due to its low abundance, but it was shown to bind Boc-FL after
recombinant overexpression and purification. Mutants lacking Lmo2812 and another low molecular mass (LMM)
PBP, PBP5 (PBPD1) - both with DD-carboxypeptidase activity - displayed only slight morphological alterations,
demonstrating that they are dispensable for cell survival and probably participate in the latter stages of
peptidoglycan synthesis. Since Lmo2812 preferentially degrades low-molecular- mass substrates, this may indicate a
role in cell wall turnover.
Background
Penicillin-binding proteins (PBPs) are responsible for the
final synthesis steps of the universal peptidoglycan exos-
keleton of bacteria. Since their initial identification by
Brian Spratt [1] most attention has been paid to the
activities of these proteins in model microorganisms such
as Escherichia coli, Bacillus subtilis and Streptococcus
pneumoniae.
The rise in resistance to b-lactam antibiotics and the
diversity of the mechanisms involved, including modifi-
cation of the target PBPs often seen in Gram-positive
pathogens, has resulted in increased interest in this
group of proteins.
Listeria monocytogenes causes relatively infrequent but
often very serious food-borne infections termed lister-
ioses, with mortality rates that can reach 25-30% [2-4].
Newborns and immunocompromised individuals are at
special risk, and in these cases controlling the infection
with antimicrobial agents can potentially be hindered
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due to the emergence of L. monocytogenes isolates with
reduced susceptibility to ampicillin [5,6].
The penicillin-binding proteins (PBPs) of L. monocyto-
genes were first identified by Vicente et al. [7] using
radiolabeled b-lactams, and it was subsequently sug-
gested that PBP3 is the primary lethal target of these
antibiotics [8,9]. However, as in many other bacteria, the
exact mechanism of b-lactam-induced cell death
remains unknown. There have been a limited number of
reports dealing with the PBPs of L. monocytogenes.
Earlier studies carried out in our laboratory - when only
five PBPs were known - resulted in a re-estimation of
the copy number of individual L. monocytogenes penicil-
lin-binding proteins [10] and elucidation of the enzy-
matic properties of PBP4 (encoded by lmo2229) and
PBP5 (lmo2754) [11-13]. A different approach to study-
ing the penicillin-binding proteins of L. monocytogenes
was made possible by the availability of the complete
genome sequence of this bacterium [14]. The insertional
mutagenesis of genes encoding seven potential PBPs
-two of class A, three of the high molecular mass
(HMM) class B and two of the low molecular mass
(LMM) type - helped to clarify their role [15].
In the present study we have positively identified eight
penicillin-binding proteins in whole cell extracts of
L. monocytogenes, and another LMM PBP (Lmo2812)
was characterized by the Bocillin-FL (Boc-FL)-binding
ability of the purified recombinant protein.
Results
Detection and identification of L. monocytogenes PBPs
The “surfaceome” of the model L. monocytogenes strain
EGDe has been annotated [14] and recently revised [16].
It includes proteins involved in the synthesis of peptido-
glycan. Examination of sequence information from a
database dedicated to the analysis of the genomes of
L. monocytogenes (strain EGDe) and its non-pathogenic
relative Listeria innocua (strain CLIP 11262) http://
genolist.pasteur.fr/ListiList, as well as that from the
Pfam database http://www.sanger.ac.uk/Software/Pfam
and information from the NCBI Conserved Domain
database http://www.ncbi.nlm.nih.gov/COG/ and the
Interpro database http://www.ebi.ac.uk/interpro/, has
identified 10 putative genes for PBPs, classified accord-
ing to molecular class (Table 1).
PBPs form a covalent complex with b-lactam antibio-
tics [1]. When fluorescent b-lactams are employed, these
proteins can be visualized immediately following SDS-
PAGE [17]. Total protein from whole cells or a cell wall
extract of L. monocytogenes EGD were incubated with dif-
ferent concentrations of Boc-FL, Bocillin-650 (Boc-650)
or Ampicillin-Alexa430 (Amp-430) for 30 min at 37°C.
The highest affinity binding was obtained with Boc-FL
and bands identified using this compound in the whole
cell assay are shown in Figure 1. PBPs A1, B2, B1, A2,
B3, D1, C1 and C2 were also identified with Boc-650 and
Amp-430 (data not shown). Two types of non-specific
band were also observed (lane 1, 0 μM Boc-FL) and they
represent the natural intrinsic fluorescence of other pro-
teins in the cell extract. However, the bands that are
absent in lane 8 (ampicillin 100 μg/ml, 50 μM Boc-FL)
compared with lane 7 (50 μM Boc-FL) represent specific
PBPs. Those bands that completely disappeared (PBPB1,
PBPD1), partially disappeared (PBPA1, PBPB2, PBPA2
and PBPB3) or remained present (PBPC1 and PBPC2)
reflect total, partial and no binding of ampicillin, respec-
tively. The results of an experiment examining saturation
with 50 μM Boc-FL, the binding capacity of each PBP for
Boc-FL and the affinity of the PBPs for ampicillin (Amp)
are presented in Table 2. These assays involved incuba-
tion of whole cell with ampicillin followed by a similar
incubation with Boc-FL. Therefore, only those PBPs with
no or low affinity for ampicillin would be able to bind
Boc-FL during the second incubation. The deacylation
rate for the PBPs is actually extremely low, which per-
mitted their detection in the gel for several hours after
binding. Boc-FL binding to PBPs B1 and D1 was comple-
tely inhibited by Amp at 100 μg/ml, and these two PBPs
exhibited high (Kd50 = 0.25 μM) and medium (Kd50 =
5.0 μM) affinity for Boc-FL, respectively. PBPs A1, B3, C1
and C2 showed low affinity (Kd50 >10 μM) for Boc-FL.
Characterization of protein Lmo2812 (PBPD2)
Gene lmo2812 was amplified by PCR from the wild-type
EGD strain and cloned in vector pET30a without its
putative lipobox signal peptide. Expression of the His-
tagged fusion protein in E. coli BL21(DE3) cells was
induced with IPTG and it was purified from cell lysates
on a nickel affinity column. The recombinant Lmo2812
protein was eluted from the column by washes with 250
and 500 mM imidazole. These two fractions were com-
bined and further purified on a desalting column, yield-
ing 4 mg/ml of pure protein.
The purified protein was incubated with different con-
centrations of Boc-FL (0.25, 0.5, 2.5, 5 and 10 μM).
Saturation binding studies showed that Lmo2812 cova-
lently bound Boc-FL, indicating that the recombinant
protein retained its authentic activity. Lmo2812 was the
major band on gels, with a slower migrating minor band
thought to represent a dimeric form (Figure 2).
The b-lactam binding capacity of Lmo2812 was evalu-
ated with three different fluorescent antibiotics: Boc-FL,
Boc-650 and Amp-430. The purified protein was able to
bind these compounds with apparent affinity constants
(Kd50) of 2.5, 2.8 and 18.5 μM, respectively.
Since most LMM PBPs are DD-carboxypeptidases,
the enzymatic activity of Lmo2812 was characterized
in an in vitro assay using the synthetic tripeptide Na,
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Nε-Diacetyl-Lys-D-Ala-D-Ala at concentrations of up
to 12.5 mM as substrate with 40 μg of purified protein.
The maximum activity was 0.75 pmoles/μg min, indi-
cating low DD-carboxypeptidase activity under these
assay conditions.
No b-lactamase activity could be detected in assays
performed using the purified protein (data not shown).
The hydrolysis of whole peptidoglycan and purified
natural muropeptides was also analyzed, but no such
enzymatic activity was detected when the purified
Lmo2812 (up to 100 μg of protein) was incubated for
up to 18 h in the presence of 300 μg of whole peptido-
glycan or up to 30 μg of the natural dimeric muropep-
tide D45 (NAcGlc-NAcMur-tetrapeptide-NAcGlc-
NAcMur-pentapeptide). However, Lmo2812 was found
to cleave the peptide bond between the subterminal and
terminal D-alanine moieties (positions 4 and 5) of the
pentapeptide side chain of the monomeric muropepep-
tide M5 (NAcGlc-NAcMur-pentapeptide) to convert the
pentapeptide into a tetrapeptide M4 (NAcGlc-NAcMur-
tetrapeptide). No such cleavage occurred in the absence
of Lmo2812.
The pH-dependence of the activity of Lmo2812
against monomeric muropepeptide M5 was determined
in the pH range of 4.5 to 7.0. The highest activity was
detected in assays performed at pH 7.0 in a Tris-Mg
buffer, where half of the substrate was converted to the
tetrapeptide (Table 3).
Construction of single and double penicillin-binding
protein mutants
Allelic exchange mutagenesis was used to create in-frame
deletions in the lmo2812 and lmo2754 genes, which
encode the penicillin-binding proteins Lmo2812 (PBPD2)
and PBP5 (PBPD1), respectively. DNA fragments repre-
senting regions near the 5′ and 3′ ends of the genes were
independently amplified, spliced, and inserted into the
E. coli - L. monocytogenes shuttle vector pKSV7 to gener-
ate derivatives pKD2812 and pADPBP5, carrying the
spliced regions of the lmo2812 and lmo2754 genes,
respectively. L. monocytogenes cells transformed with
these constructs were grown for several generations in
TSBYE broth at 30°C in the presence of chloramphenicol
to select for chromosomal integration of the plasmids.
Table 1 The full set of predicted PBPs in L. monocytogenes
PBPa PBPb genec Classd Prototype aa MW (kDa) IP Putative domain structuree
PPBA1 PBP1 lmo1892 A-3 PBP1a (Spn) 827 90.87 9.15 SP-F-TG-TP
PBPB2 PBP2 lmo2039 B-4 PBP2x(Spn) 751 81.89 7.77 SP-F-D-TP
PBPB1 PBP3 lmo1438 B-5 PBP2b(Spn) 721 79.91 8.26 SP-F-D-TP
PBPA2 PBP4 lmo2229 A-4 PBP2a(Spn) 714 77.85 6.75 SP-F-TG-TP
PBPB3 ——— lmo0441 B-1 PBP2a(Sau) 678 74.60 6.57 SP-F-MecAN-D-TP
PBPD1 PBP5 lmo2754 C-T5 PBP3(Spn) 445 48.08 7.63 SP-CP-CA
PBPC1 ——— lmo0540 C-TH AmpH(Eco) 397 44.53 9.70 SP-BLA
PBPC2 ——— lmo1916 C-TH R61 (SR61) 335 37.84 7.04 BLA
PBPD3 ——— lmo1855 M15B —— 274 31.08 5.46 SP-CP(VanY)
PBPD2 ——— lmo2812 C-T5 PBP5 (Bsu) 272 29.48 4.59 SP(lipo)-CP
aNomenclature of PBPs as defined in [16]; bNomenclature of PBPs as defined in [7,10]; cgene names as identified in Listilist web server http://genolist.pasteur.fr/
ListiList/; dspecific class of PBP as identified in [19]; edomain structure of PBPs as described in [16]; SP, signal peptide; F, hydrophobic region; TG, transglycosylase
domain; TP, transpeptidase domain; D, interaction domain; MecAN, homologous to PBP2a S. aureus resistance protein; CP, carboxypeptidase domain; CA, C-
terminal anchor domain; BLA, b-lactamase domain; (VanY), homologous to VanY; SP(lipo), lipoprotein signal peptide.
Figure 1 Complete set of PBPs identified with Boc-FL in whole cells of L. monocytogenes. Samples of whole cells (100 μg of total protein)
were labeled with Boc-FL at concentrations of 0 (1), 0.5 (2), 1 (3), 2.5 (4), 5 (5), 10 (6), 50 μM (7) and 50 μM plus 100 μg/ml ampicillin (8).
Labeled bands were detected directly on the gel, quantified, and their molecular mass estimated. The affinity of each band for Boc-FL (ID50) was
estimated from their fluorescence as a function of the concentration of Boc-FL. The name of the PBP corresponding to each band is indicated
on the right, while the positions of molecular weight markers (bars) and unspecific bands (arrowheads) are shown on the left.
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Excision of chromosomally-integrated plasmids was facili-
tated by repeated growth in the absence of antibiotic
pressure, and a subsequent shift in the growth tempera-
ture was used to cure the cells of the excised plasmids.
Colonies grown on TSBYE plates were screened for loss
of chloramphenicol resistance and several sensitive clones
were then examined by PCR to identify those in which
an allelic exchange event had resulted in chromosomal
replacement of the wild-type copy of the gene with the
mutant allele. This first round of allelic exchange muta-
genesis led to the isolation of the derivative L. monocyto-
genes KD2812, which had a 627-bp deletion in the
lmo2812 gene.
The KD2812 single mutant was used in a second
round of allele replacement mutagenesis, which began
with the transformation of this strain with plasmid
pADPBP5. Completion of the mutagenesis procedure
led to the isolation of a double-mutant strain, L. mono-
cytogenes AD07, which had a 627-bp deletion in the
lmo2812 gene and a 1113-bp deletion in the lmo2754
(PBP5) gene.
Characterization of KD2812 and AD07 mutant strains
To examine the effect of PBP deletion on cell growth
rate, the doubling times of cultures of EGD, KD2812
and AD07 were determined. The doubling time of the
wild-type strain grown at 37°C was 40 min, whereas
those of the single and double mutants were 45 and 50
min, respectively. These data indicate that the single
and double PBP deletion strains grew significantly
slower (P < 0.05) than EGD. The doubling time of the
double mutant was also significantly different from that
of KD2812. Thus, although the bacteria were viable in
the absence of Lmo2812 and PBP5, they grew more
slowly than the wild-type.
To determine the effect of these mutations on cell
morphology, the strains EGD, KD2812 and DA07 were
analyzed by scanning electron microscopy (SEM). As
cells of the mutant strains displayed irregular morphol-
ogy when grown at 42°C (Figure 3; h, i), the cell lengths
were only determined when the strains were grown at
30 and 37°C. Cells of the L. monocytogenes strains lack-
ing Lmo2812 were significantly longer than those of the
wild-type (Student’s t test, P < 0.05) (Table 4). At 30°C
the average cell length compared to strain EGD was
increased by 38.5% in strain KD2812 and by 44.8% in
the double mutant strain. The respective values at 37°C
were 37.5% and 43%. The populations of the single and
double mutant strains also showed some variation in
cell morphology. A proportion of the cells of strain
KD2812 showed an altered phenotype at each of the
tested temperatures. The variant cells were characteristi-
cally curved with a bend at either one or both ends and
subterminal constrictions. The number of cells with
altered morphology was increased as the growth tem-
perature was raised (Figure 3; b, e, h). Cell bending was
more pronounced in the population of AD07 mutant
cells (Figure 3; c, f, i). More than 90% of cells of the
double mutant exhibited irregular morphology at 42°C.
To determine whether disruption of the PBP-encoding
Table 2 Competition binding assay and affinity of
different PBPs of L. monocytogenes for Boc-FL
PBP Boc-FL Kd50a Ampicillinc
PPBA1 (PBP1) >10 μM 95
PBPB2 (PBP2) 0.25 μM 90
PBPB1 (PBP3) 0.25 μM 0
PBPA2 (PBP4) 0.25 μM 90
PBPB3 >20 μM 95
PBPD1 (PBP5) 5.0 μM 0
PBPC1 >20 μM 100
PBPC2 >20 μM 100
PBPD3 n.a. n.a.
PBPD2 2.5 μMb 0b
aaffinity of the respective bands for Boc-FL estimated from their fluorescence
as a function of the concentration of Boc-FL (Kd50)
bobtained with purified recombinant Lmo2812
cpercentage of Boc-FL binding capacity remaining after sample was
preincubated with 100 μg/ml ampicillin
Figure 2 Purified recombinant L. monocytogenes Lmo2812
(PBPD2) identified with Boc-FL. Samples of purified recombinant
Lmo2812 (10 μg) were labeled with Boc-FL at concentrations of 0
(1), 0.25 (2), 0.5 (3), 2.5 (4), 5 (5) and 10 μM (6). Labeled bands were
detected directly on the gel, quantified and their molecular mass
estimated. The affinity of the bands for Boc-FL (Kd50) was estimated
from their fluorescence as a function of the concentration of Boc-FL.
The names of the bands are indicated on the right, and the
positions of the molecular weight markers are shown on the left.
Table 3 DD-carboxypeptidase activity of recombinant
Lmo2812 using M5 muropeptide as the substrate
Reaction conditions M5 (%)a M4 (%) a
Lmo2812, M5, pH 4.5 97 3
Lmo2812, M5, Tris-Mg, pH 7.0 52 48
Lmo2812, M5, NaPi, pH 7.0 84 16
Control, M5, pH 7.0 99 1
apercentage of muropeptides M5 (NAcGlc-NAcMur-pentapeptide) and M4
(NAcGlc-NAcMur-tetrapeptide) determined by HPLC analysis
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genes had an impact on the b-lactam resistance of
L. monocytogenes, microdilution MIC tests were per-
formed. The results demonstrated that the lack of func-
tional lmo2812 and lmo2754 genes had little effect on
the sensitivity of the mutant strains to the panel of
b-lactam antibiotics tested (Table 5). Similar results
were found for a mutant of L. monocytogenes lacking
PBP5 (PBPD1) examined in a previous study [11].
To compare the murein of L. monocytogenes mutants
KD2812 and AD07 with that of the wild-type strain,
muropeptides were released from isolated peptidoglycan
by complete digestion with muramidase and the reduced
muropeptides were analyzed by high performance liquid
chromatography (HPLC) to that obtained for wild-type
L. monocytogenes, but that of the double mutant was
markedly different (Figure 4). Comparison of the pepti-
doglycan profiles of the wild-type strain and AD07
(Figure 4; A and 4C) indicated that both the composi-
tion and relative amount of a number of muropeptides
were dramatically altered. All of the well characterized
muropeptides identified in the murein of strain EGD,
with tripeptide side chains in monomers or cross-linked
Figure 3 Morphology of L. monocytogenes EGD and PBP mutants. SEM images of cells of wild-type strain EGD (a, d, g), mutant KD2812 (b,
e, h) and mutant AD07 (c, f, i). The growth temperatures of the cultures were 30°C (a to c), 37°C (d to f) and 42°C (g to i). Arrows indicate
irregularly curved cells and increased cell length.
Table 4 Cell length of L. monocytogenes EGD and mutant strains grown at different temperatures
Temperature Strain Average cell length (μm) ± SD Minimum length/Maximum length (μm) n
30°C EGD 1.70 ± 0.38 0.99/3.80 245
KD2812 2.35 ± 0.76 1.19/6.97 124
AD07 2.46 ± 0.68 1.44/6.43 111
37°C EGD 1.80 ± 0.44 1.05/3.64 150
KD2812 2.48 ± 0.70 1.43/4.70 106
AD07 2.581 ± 0.6 1.56/5.15 50
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muropeptides (e.g. muropeptides 1, 2, 3, 4, 5), were dra-
matically decreased or entirely absent in the double
mutant. Furthermore, a number of novel muropeptides
(B1 to B7) were detected in AD07 pepidoglycan. Peaks
B1 and B2 may correspond to monomers with a disac-
charide-pentapeptide structure, while B3-B7 may repre-
sent different forms of a dimer - a bis-disaccharide
penta-tetra [18].
Discussion
Previous analyses [7-10] of the L. monocytogenes cell
membrane identified only five proteins able to bind I125-
penicillinX, H3-benzylpenicillin, S35-penicillin or I125-
ampicillin (PBP1, PBP2, PBP3, PBP4, PBP5), which cor-
respond to PBPA1, B2, B1, A2 and D1, respectively.
In silico analysis of the L. monocytogenes genome
revealed the presence of ten open reading frames that
potentially encode penicillin-binding proteins [16]. We
believe that the present study is the first to have used
fluorescently labeled antibiotics (Boc-FL, Boc-650 and
Amp-430) to identify the PBPs of L. monocytogenes.
With this method, we were able to identify eight PBPs,
both in whole cell and membrane extracts. PBPB3,
encoded by the gene lmo0441, was classified as a sub-
class B1 PBP [19]. All PBPs in this subclass, e.g. PBP2a
of Staphylococcus aureus and PBP5 of Enterococcus fae-
cium, are thought to exhibit low affinity for penicillin
[20]. We found that PBPB3 also has low affinity for all
the b-lactams tested. A recent study of seven L. monocy-
togenes genes encoding potential penicillin-binding
proteins showed that interruption of the lmo0441 gene
resulted in increased susceptibility of strain EGDe to b-
lactams [15]. It was concluded that protein Lmo0441
(PBPB3) may play a central role in the b-lactam resis-
tance of L. monocytogenes [15]. We identified two addi-
tional LMM PBPs, PBPC1 and PBPC2, which contain a
b-lactamase class C domain. PBPC1 is predicted to be
located at the surface of the bacterium, while PBPC2
lacks any recognized cell surface association domain
[16]. However, we detected both proteins in intact cells,
which indicates that some physical interaction of PBPC2
with the cell wall must exist.
The product of gene lmo1855, Lmo1855 (PBPD3), was
not found to bind b-lactams with any of the various
methods employed and consequently cannot be consid-
ered a PBP.
Lmo2812 (PBPD2), a low molecular mass PBP, has
been identified as a class C type 5 protein related to the
peptidase S11 family [19]. As Lmo2812 was not
observed in Boc-FL-, Boc-650- and Amp-430-labeled
extracts, it seemed possible that it does not bind b-lac-
tam antibiotics. However, b-lactam binding experiments
with purified recombinant protein demonstrated that
Lmo2812 does bind the three different fluorescent anti-
biotics efficiently. The apparent affinity constants
(Kd50) for Boc-FL, Boc-650 and Amp-430 were 2.5, 2.8
and 18.5 μM, respectively. The absence of an observable
band corresponding to Lmo2812 following SDS-PAGE
of the Boc-FL-labeled listerial extract cannot be due to
lack of interaction with the b-lactam. This result sug-
gests that L. monocytogenes grown in culture expresses
this protein at a very low level. It has recently been
shown that the two-component system CesRK controls
the transcriptional induction of lmo2812. The expres-
sion of lmo2812 is positively regulated by CesR and
inducible with ethanol and cefuroxime [21]. On the
other hand, we were able to identify protein Lmo0441
in a whole cell extract using fluorescent-labelled anti-
biotics, and the expression of this PBP is also dependent
on CesR [21].
Bacteria often have a major type-5 PBP which repre-
sents the most abundant LMM PBP they produce. The
most highly expressed PBP in listerial membranes is
PBP5. In a previous study we confirmed that PBP5 is a
DD-carboxypeptidase that preferentially degrades low-
molecular-weight substrates [11]. In the present study
we found that PBP5 is also a protein with a high affinity
for b-lactams.
L. monocytogenes produces one more type-5 PBP -
Lmo2812 - but its role in cell wall biosynthesis and cat-
alytic activity had not previously been examined. In this
study, recombinant Lmo2812 was expressed in E. coli
and purified in order to characterize its enzymatic activ-
ity and role in cell physiology. Lmo2812 lacking its sig-
nal sequence was expressed as a His-tagged fusion
protein in the cytoplasm of E. coli, which allowed the
purification of large amounts of functionally active
protein.
Type-5 PBPs, with the exception of S. aureus PBP4,
are strict DD-carboxypeptidases and are unable to cata-
lyze transpeptidation reactions [19]. Using the synthetic
tripeptide Na,Nε-Diacetyl-Lys-D-Ala-D-Ala and the nat-
ural monomer NAcGlc-NAcMur-pentapeptide in an
in vitro assay, we showed that Lmo2812 displays weak
Table 5 MICs of some b-lactam antibiotics against L.
monocytogenes EGD and mutant strains
Antimicrobial agent MIC (μg/ml)
EGD KD2812 AD07
penicillin 0.16 0.16 0.08
ampicillin 0.31 0.31 0.16
oxacillin 2.5 2.5 1.25
piperacillin 1.25 1.25 1.25
cefalotin 2 2 2
cefoxitin 32 32 32
cefotaxim 6 6 6
ceftazidime 256 256 256
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Figure 4 HPLC elution patterns of muropeptides from wild-type and mutant L. monocytogenes peptidoglycan. Muropeptides produced
by the enzymatic hydrolysis of peptidoglycan purified from wild-type L. monocytogenes EGD (A), mutant KD2812 lacking functional Lmo2812 (B),
and mutant AD07 lacking functional Lmo2812 and PBP5 (C), were reduced and separated by reversed phase HPLC and the A205 of the eluate
was monitored: 1, 2 disaccharide-tripeptide monomers; 3,4,5 bis-disaccharide tri-tetra peptide dimers.
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DD-carboxypeptidase activity, cleaving the peptide bond
between the subterminal and terminal D-alanine moi-
eties. However, the recombinant Lmo2812 was active
against neither E. coli peptidoglycan nor the natural
dimeric muropeptide D45 (disaccharide pentapeptide
disaccharide tetrapeptide). This suggests that Lmo2812,
like PBP5 [11], preferentially degrades low-molecular-
weight substrates. Analysis of the muropeptide profiles
of a L. monocytogenes mutant demonstrated that the
lack of Lmo2812 activity does not affect the muropep-
tide structure of its peptidoglycan. However, the ratio of
pentapeptides to tripeptides was found to be increased
in cells lacking both Lmo2812 and PBP5. Similar
changes have been observed in the peptidoglycan from a
L. monocytogenes mutant lacking PBP5 [12], B. subtilis
devoid of PBP5 [18] and S. pneumoniae with disrupted
PBP3 activity [22]. These changes in the muropeptide
profile indicate that L. monocytogenes PBP5, like PBP5
of B. subtilis and PBP3 of S. pneumoniae, is a DD-car-
boxypeptidase that plays a basic role in the maturation
of the cell wall peptidoglycan.
Mutations in genes coding for low molecular mass PBPs
are not lethal for the bacterial cell and in general these
proteins seem to be redundant. Mutants can survive not
only the lack of individual LMM PBPs, e.g. Pseudomonas
aeruginosa [23], S. pneumoniae [24], S. aureus [25] and
Myxococcus xanthus [26], but also the loss of all LMM
PBPs, e.g. E. coli [27], Neisseria gonorrhoeae [28] and
B. subtilis [29]. Similarly, we demonstrated that the inacti-
vation of L. monocytogenes genes lmo2812 and lmo2754 is
not lethal and these gene products are dispensable for the
growth and survival of the cells.
The results of the present and previous studies indi-
cate that the growth of L. monocytogenes is only slightly
impaired when it lacks the activities of Lmo2812 or
both Lmo2812 and PBP5 [11,12]. Reduced growth rates
have also been reported for a S. pneumoniae mutant
lacking functional PBP3 [24] and for a double N. gonor-
rhoeae mutant lacking both PBP3 and PBP4 [28]. On
the other hand, no changes in growth rate were
observed for E. coli or B. subtilis mutants lacking most
or all of their DD-carboxypeptidase activity [27,29].
However, the loss of Lmo2812 did result in significant
changes in morphology. The mutant cells were signifi-
cantly longer, slightly curved and had bent ends. These
changes were even more pronounced in the double
mutant AD07 lacking both Lmo2812 and PBP5. This
finding is interesting because we did not notice any
alterations in cell shape in a L. monocytogenes mutant
lacking PBP5 alone, although the cell wall of the mutant
was much thicker than that of the parental strain
[11,12], even though Guinane et al. [15] did describe
such changes. The differences between our observations
may be due to variation in the strain (EGD versus
EGDe) or growth conditions employed [15].
The reason for the prominent morphological changes
in strain KD2812 is difficult to pinpoint since there do
not seem to be any remarkable changes in the muro-
peptide structure of the peptidoglycan of this mutant.
However, the observed changes in cell morphology
implicate the protein in the late stages of peptidoglycan
synthesis, presumably in the determination of the avail-
ability of pentapeptide substrates. Our finding that
Lmo2812 preferentially degrades low-molecular-weight
substrates may point to the a role for this protein in
cell wall turnover. Further studies are required to clarify
the function of Lmo2812, although, as in the case of
extensive studies on the D-alanine carboxypeptidases of
E. coli [30] and other bacteria, they may not yield con-
clusive results.
Conclusions
The results of this study conclusively show that nine
of the ten previously identified putative PBP genes of
L. monocytogenes code for proteins that bind b-lactam
antibiotics and their labeled or fluorescent derivatives.
Eight of these proteins were identified in whole cell
extracts, whereas the ninth protein, Lmo2812, was only
shown to bind b-lactams following expression in
E. coli and subsequent purification by affinity chroma-
tography. The inability to detect Lmo2812 activity in
the L. monocytogenes cell may be explained by the low
abundance of this protein, whose expression is regu-
lated by the two-component system CesRK [21]. We
have also demonstrated that the LMM PBP Lmo2812
is a DD-carboxypeptidase and has no discernible
b-lactamase activity. Mutants lacking the protein grow
normally, although their cells are often longer and
slightly curved. Similar morphological changes were
observed in the case of a double mutant lacking two
LMM carboxypeptidases: Lmo2812 and Lmo2754. Our
results indicate that Lmo2812 most probably partici-
pates in the late stages of peptidoglycan synthesis, in
the determination of the availability of pentapeptide
substrates. Moreover, the fact that Lmo2812 preferen-
tially degrades low-molecular-weight substrates may
point to a role in cell wall turnover. The product of
the tenth putative PBP gene, Lmo1855, was not found
to bind b-lactams with any of the various methods
employed and consequently cannot be considered a
PBP. In this respect it resembles the homologous pro-
tein VanY from VanA- and VanB-type enterococcal
strains. This study extends the number of identified
penicillin-binding proteins from the original five [7,10]
to the final number of nine which represents the full
set of these proteins in L. monocytogenes.
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Methods
Strains, plasmids and growth conditions
E. coli BL21(DE3) and DH5a were grown aerobically at
37°C on Luria-Bertani (LB) medium. L. monocytogenes
strains were grown on Tryptic Soy Broth Yeast Extract
(TSBYE) and Brain Heart Infusion (BHI) media at 37°C
unless otherwise stated. Plates of solid LB or TSBYE
media were prepared following the addition of agar to
1% (w/v). Ampicillin (100 μg/ml) or kanamycin (30 μg/
ml) and chloramphenicol (10 μg/ml) were added to
broth or agar media as required. When necessary, 0.1
mM IPTG (isopropyl b-D-1-thiogalactopyranoside) and
X-Gal (5-bromo-4-chloro-3-indolyl-b-D-galactopyrano-
side) (20 μg/ml) were spread on agar plates 30 min
prior to plating. The bacterial strains, plasmids and oli-
gonucleotide primers used in this study are shown in
Tables 6 and 7.
Construction of L. monocytogenes mutant strains
(i) Construction of the Δlmo2812 single mutant
The splicing by overlap extension (SOE) PCR approach
was used to create an internal deletion construct for the
lmo2812 gene. Primers La2812 and Pb2812 (Table 7)
were used to amplify a 545-bp fragment comprising the
5′ end of lmo2812, and primers Lc2812 and Pd2812
were used to amplify a 522-bp fragment comprising the
3′ end of this gene from genomic DNA L. monocyto-
genes EGD. The two fragments were purified and used
as the templates in a third PCR with primers La2812
and Pd2812, which generated a Δlmo2812 allele with a
627-bp deletion extending from nucleotides +73 to
+700. Deletions in the gene lmo2754 were constructed
by a similar approach using SOE primers shown in
Table 7. The Δlmo2754 allele has a 1113-bp deletion
(extending from nucleotides +86 to +1219). The
Δlmo2812 and Δlmo2754 alleles were ligated as blunt-
ended fragments to SmaI-digested E. coli-L. monocyto-
genes shuttle vector pKSV7 [31] and used to transform
E. coli DH5a to generate plasmids pKD2812 and
pADPBP5, respectively. pKD2812 was introduced into
L. monocytogenes EGD by electroporation [32] and
transformants were selected on TSBYE plates containing
10 μg/ml chloramphenicol. The transformants were
grown briefly at 30°C and then plated on TSBYE plus
chloramphenicol and grown at 42°C to select for inte-
gration of the plasmid by homologous recombination.
Colonies with a chromosomal integration were then
serially propagated in TSBYE without chloramphenicol
at 30°C. Single clones were picked and replica plated on
TSBYE and TSBYE plus chloramphenicol to identify
those having undergone excision and loss of the plas-
mid. The presence of the desired allelic exchange in
chloramphenicol-sensitive colonies was then confirmed
by PCR using primers La2812 and Pd2812. The result-
ing mutant strain with a deletion in the lmo2812 gene
was designated KD2812.
Table 6 Strains and plasmids used in this study
Strain or plasmid Relevant genotype and features Reference or source
strains
EGD L. monocytogenes wild-type
KD2812 Δlmo2812 derivative of EGD This work
AD07 Δlmo2754 derivative of KD2812 This work
E. coli DH5a F- F80 Δ lacZM15(lacZYA-orgF) U169 deoR recA1 endA1 hsd R17 phoA supE44kl-thi-1 gyrA96 relA1
E. coli BL21(DE3) F- ompT gal dcm hsdSB(rB
- mB
-) l(DE3) Novagen
plasmids
pET30a Novagen
pAD3 pET30a derivative containing lmo2812 gene This work
pKSV7 temperature-sensitive integration vector; MCSa; lacZ; b-lac; cat, pE194 Ts rep [31]
pKD2812 pKSV7 carrying the Δlmo2812 allele This work
pADPBP5 pKSV7 carrying the Δlmo2754 allele This work
aMCS - multiple cloning site
Table 7 Oligonucleotide primers used in this study
primer Sequence 5’!3’
pET6up3a AGCAAATCATATGGCGGTTTATTCAGTCG
pET6downa ATGCTCGAGATCTTCTTTAAACCCAACCTC
La2812 ATCCGCTATCTGAATCGCCT
Pb2812b TTCAGCTGTTCCAATTATTGCTCCGTAGAACAGGCTG
Lc2812 TTGGAACAGCTGAACGTGGA
Pd2812 CTAGAGTCAATCCGCAGCCA
La2754 CCGTTATTGACATCTGCTAC
Pb2754b CCGCAGAAGCACCAATAACTGCCAGCGACGTTGAA
Lc2754 TTGGTGCTTCTGCGGCTTGT
Pd2754 TAGCAGATGGCATCATCCGG
a Nucleotide substitutions to create restriction sites are underlined
b Overhangs complementary to SOE primers are underlined
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(ii) Construction of a Δlmo2812 Δlmo2754 double mutant
A double mutant strain was constructed by introducing
the pKSV7 derivative pADPBP5 into L. monocytogenes
KD2812 by electroporation. This was followed by the
integration excision, curing and screening steps
described above. The desired allelic exchange event was
confirmed by PCR using the primers La2754 and
Pd2754, and a PBP assay. The resulting mutant strain
with deletions in the lmo2812 and lmo2754 genes was
designated AD07.
Inducible expression of recombinant Lmo2812 protein
Recombinant expression experiments were performed
with E. coli BL21(DE3) harboring a derivative of the vec-
tor pET30a (Novagen). The lmo2812 gene without its
signal sequence was amplified from L. monocytogenes
EGD genomic DNA using primers designed from its
sequence in GenBank (accession number AL591984).
The upstream primer pET6up3 (Table 7) annealed to
lmo2812 codons 33-38 and contained an in-frame NdeI
restriction site at the 5′-end and a translation initiation
codon in frame with the triplet coding for the first resi-
due of the mature Lmo2812, whereas the downstream
primer pET6down annealed to the last seven codons of
the coding sequence and contained a XhoI site at the
5′-end. The PCR thermocycle was performed using a
gene cycler (Amersham Biotech) and consisted of an
initial denaturation for 5 min (94°C) followed by
30 cycles of amplification (30 s at 94°C, 30 s at 55°C
and 45 s at 72°C) and a final extension for 10 min at
72°C. The amplified fragment was digested with NdeI
and XhoI and cloned into vector pET30a that had been
digested with the same endonucleases, which fused
lmo2812 with a sequence encoding a hexahistidine pep-
tide. The cloned insert was sequenced and found to be
identical to the lmo2812 sequence in the completed
EGDe genome (accession number AL591984). The
expression plasmid pAD3 (pET30a-lmo2812) was used
to transform E. coli BL21(DE3).
Overexpression and purification of a soluble recombinant
form of Lmo2812
For the expression of recombinant Lmo2812 protein, an
overnight culture of strain BL21(DE3) harboring the
plasmid pAD3 was diluted 1:100 into 1 litre of LB med-
ium and this was incubated with shaking at 37°C. When
the OD600 reached 0.6, IPTG (isopropyl b-D-1-thioga-
lactopyranoside; Sigma, 1 mM) was added and the cul-
ture was shaken at 37°C for 24 hours. The culture was
cooled on ice and the cells were then harvested by cen-
trifugation (7000 × g, 15 min, 4°C). All subsequent steps
in the purification of the protein were performed at 4°C.
The cell pellet was resuspended in 50 mM sodium phos-
phate buffer (NaPi), pH 8.0 containing 0.3 M NaCl and
0.1% Tween-20. After adding DNase (10 μg/ml) and
phenylmethanesulfonyl fluoride (1 mM), the cells were
broken by sonication (VCX-600 ultrasonicator Sonics
and Materials, USA). Cell debris was removed by centri-
fugation (7000 × g, 15 min, 4°C). and the cell lysate
supernatant containing the fusion protein was applied to
a 5 ml nickel column according to the manufacturer’s
instructions (Qiagen). The column was washed with
wash buffer (50 mM NaPi buffer pH 8.0, 0.3 M NaCl,
20 mM imidazole, 10% glycerol). The bound proteins
were then eluted with a 50 mM 1 M gradient of imida-
zole in elution buffer (50 mM NaPi buffer pH 8.0,
0.3 M NaCl) at a flow rate of 40 ml/h. Protein purity
was determined by SDS-PAGE. Fractions 9-10 (2.5 ml
each) containing recombinant Lmo2812 were combined
and further purified on an Econo-Pac 10 DG (Bio-Rad)
desalting column against column running buffer
(50 mM NaPi buffer pH 7.0, 50 mM NaCl), following
the manufacturer’s instructions.
Fluorescent antibiotic binding assay
Total whole cell proteins or purified recombinant pro-
tein resuspended in 50 mM NaPi buffer, pH 7.0 were
labeled by incubation at 37°C for 30 min with different
concentrations of Boc-FL (Molecular Probes), Boc-650
(Molecular Probes) or Amp-430 (prepared in the labora-
tory by coupling ampicillin to Alexa-430), and then
separated on a 10% acrylamide, 3.3% cross-linkage SDS-
PAGE gel. To avoid degradation of the fluorescent
b-lactam antibiotics by b-lactamases, samples were incu-
bated at 37°C with clavulanic acid at a final concentra-
tion of 10 μg/ml or EDTA at a final concentration of
10 mM for 30 min before labeling, where appropriate.
Competition experiments were carried out by preincu-
bation of the samples with ampicillin (100 μg/ml) for
30 min at 37°C, before adding the fluorescent antibiotic.
The samples were then further incubated for 30 min at
37°C. PBPs were visualized directly on the polyacryloa-
mide gel by fluorescence using a Typhoon 9410 imager
(Amersham Biosciences) with excitation wavelengths of
588, 633 or 457 nm and emission filters 520BP40,
670BP30 or 555BP20 for Boc-FL, Boc-650 and Amp-
430, respectively.
Affinity constants for the binding of the labeled b-lac-
tase to recombinant Lmo2812 were calculated from the
results of binding assays using increasing concentrations
of protein and/or antibiotic, and from the binding
curves, apparent Kd values were determined as the con-
centration of antibiotic required for 50% of maximum
binding.
b-lactamase activity assay
b-lactamase activity was determined using the nitrocefin
test (Oxoid) and quantified with 0.10 mM nitrocefin in
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50 mM NaPi (pH 7.0, 22°C) by a spectrophotometric
method. Nitrocefin (50 μg/ml) and 10 μl of extract were
incubated for 1 h in a final volume of 500 μl at room
temperature in 50 mM NaPi pH 7.0 (22°C). The absor-
bance was measured at 486 nm.
DD-carboxypeptidase activity assay
A modification of the method of Frere et al. [33] was
used for DD-carboxypeptidase activity measurement.
A reaction mixture comprised of 15 μl of Na,Nε-Diace-
tyl-Lys-D-Ala-D-Ala (25 mM), 3 μl of buffer (300 mM
Tris-HCl pH 7.5) and 12 μl of purified recombinant
Lmo2812 was prepared, incubated at 37°C and samples
were taken every 10 min for 1 h. To these samples, 5 μl
of 10 mg/ml (in methanol) o-Dianisidine (SIGMA) and
70 μl of enzyme/coenzyme mix (flavinadenine dinucleo-
tide (FAD), Peroxidase and D-Amino acid Oxidase)
were added. These mixtures were incubated at 37°C for
5 min, then 400 μl of methanol-water (v/v) was added
and incubation continued at 37°C for another 2 min.
The absorbance of each reaction was immediately read
at 460 nm. A number of controls were performed: reac-
tions containing only recombinant Lmo2812 fractions,
reactions lacking recombinant Lmo2812 to establish the
level of natural degradation of the tripeptide for at each
sampling point, and standard samples containing known
amounts of D-alanine.
Enzymatic activity assay with natural muropeptides
Whole total peptidoglycan and purified muropeptides
were isolated from E. coli cells as described previously
[34]. A 10 μg sample of recombinant Lmo2812 was
mixed with 5 μg of M5 (NAcGlc-NAcMur-pentapep-
tide) or D45 (NAcGlc-NAcMur-tetrapeptide-NAcGlc-
NAcMur-pentapeptide) in a volume of 30 μl using three
different buffer conditions: pH 4.5 (50 mM NaPi, 1%
methanol, pH 4.5), pH 7.0 (30 mM Tris-HCl, 3 mM
MgCl2, pH 7.0), or NaPi (50 mM sodium phosphate
buffer, pH 7.0). These mixtures were incubated at 37°C
for 120 min. Control samples of M5 or D45 without
Lmo2812 were similarly incubated in 30 mM Tris-HCl
buffer, 3 mM MgCl2, pH 7.0. The samples were ana-
lyzed by HPLC using a C18 reversed phase column and
a methanol gradient to separate the peaks.
Preparation of L. monocytogenes cell wall peptidoglycan
An overnight culture of the required strain (200 ml) was
cooled on ice and the cells harvested by centrifugation
(7000 × g, 10 min, 4°C). The cell pellet was resuspended
in 1/40th of the original culture volume of 50 mM Tris-
HCl buffer, pH 7.5. Glass beads (diameter 150-215 μm;
Sigma) were added to the cell suspension (1 g per ml)
prior to sonication using a VCX-600 ultrasonicator
(Sonics and Materials, USA) for ten 1 min bursts at an
amplitude of 20%. Unbroken cells were pelleted by cen-
trifugation (7000 × g, 10 min, 4°C) and the supernatant
was collected and mixed with an equal volume of hot
8% (v/v) sodium dodecyl sulfate (SDS). This mixture
was boiled for 30 min and the resulting insoluble cell
wall preparation was collected by centrifugation
(150,000 × g, 30 min, 22°C) and washed with hot dis-
tilled water (60°C) at least five times to remove SDS.
The SDS-free material was treated with a-amylase (100
μg/ml) for 2 h at 37°C, after which pronase E (200 μg/
ml) was added and the incubation continued for 90 min
at 60°C. Trichloroacetic acid was then added to a final
concentration of 5% and the cell wall suspension was
incubated for 24 h with stirring at 4°C to remove tei-
choic acid. The remaining insoluble material was col-
lected by centrifugation (150,000 × g, 30 min, 4°C) and
washed with cold distilled water until the pH became
neutral. N-acetylation of murein was performed using
acetic anhydride in the presence of NaHCO3 according
to the method of Hayashi et al. [35]. The prepared pep-
tidoglycan was stored at -20°C.
Enzymatic hydrolysis of peptidoglycan and HPLC
separation of soluble muropeptides
Prepared L. monocytogenes peptidoglycan samples
(300 μg) were digested with the muramidase Cellosyl
(Hoechst AG) as previously described [12]. Soluble mur-
opeptides were reduced by treatment with sodium boro-
hydride. The reaction was stopped after 30 min by
lowering the pH to 3.5 with phosphoric acid. The
reduced muropeptides were analyzed by HPLC on a
Hypersil octadecylsilane (ODS) reversed-phase column
(250 mm × 4 mm, particle size 3 mm diameter; Tekno-
chroma) according to the method of Glauner [34]. The
elution buffers used were 50 mM sodium phosphate
containing 0.8 g/l sodium azide, pH 4.35 (buffer A) and
15% methanol in 75 mM sodium phosphate, pH 4.95
(buffer B). Elution conditions were 7 min isocratic elu-
tion in buffer A, 115 min of linear gradient to 100% buf-
fer B and 28 min of isocratic elution in buffer B. The
flow rate was 0.5 ml/min and the column temperature
was 35°C. Eluted compounds were detected by monitor-
ing the A205.
Scanning electron microscopy
Small cultures (10 ml) of L. monocytogenes EGD, KD2812
and AD07 were grown at 30, 37 or 42°C in BHI medium
to an OD600 of 0.6 and then harvested by centrifugation
at (7000 × g, 10 min, at room temeprature). The cells
were fixed for 30 min in 4% paraformaldehyde, washed
three times in phosphate-buffered saline, pH 7.4, then
dehydrated using a graded ethanol series (25, 50, 75, 96%
ethanol; 15 min for each step). One drop of cell suspen-
sion was spread on a microcover, coated with gold, and
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examined using a LEO 1430VP scanning electron micro-
scope (SEM).
Antibiotic susceptibility tests
Microdilution tests were performed using cation-
adjusted Mueller-Hinton broth (CAMHB) supplemented
with 5% lysed horse blood containing two-fold dilutions
of the antimicrobial agents. These mixtures were dis-
pensed in 100 μl aliquots into plastic 96-well plates. To
prepare inocula, a single colony of each strain from a
TSBYE plate was transferred into 10 ml of the same
medium and incubated for 24 h at 37°C. These cultures
were serially diluted in CAMHB to a concentration of
105 cfu/ml and 100 μl aliquots were added to the micro-
dilution plates. The plates were incubated for 18-20 h at
37°C before the reading of the MIC endpoints. The MIC
was the lowest antibiotic concentration at which visible
growth was inhibited.
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